"Promising Results: CAR-T Cell Therapy Shrinks Brain Tumors in Early Trials"

A clinical trial for CAR-T cell therapy in patients with glioblastoma, a deadly form of brain cancer, has shown promising results, with some patients experiencing significant tumor regression just days after treatment. The therapy, which uses a patient's own immune cells to target the tumor, resulted in near-complete tumor regression in one patient after five days. The researchers emphasize the need for further research to refine this treatment, but are optimistic about its potential to change the outlook for this challenging disease.